Achkar Jacqueline M, Ziegenbalg Anke
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Clin Vaccine Immunol. 2012 Dec;19(12):1898-906. doi: 10.1128/CVI.00501-12. Epub 2012 Oct 24.
The identification of easily detectable biomarkers for active tuberculosis (TB) is a global health priority. Such biomarkers would be of particular value in childhood TB, which poses greater diagnostic challenges than adult TB. Serum antibodies can be detected by simple formats that provide extremely rapid results. However, attempts to develop accurate serodiagnostic tests for TB have been unsuccessful. Whereas antibody responses to mycobacterial antigens in adult TB have been studied extensively and reviewed, the same cannot be said for serologic data in pediatric populations. Here we appraise studies on serological responses in childhood TB and discuss findings and limitations in the context of the developing immune system, the age range, and the spectrum of TB manifestations. We found that the antibody responses to mycobacterial antigens in childhood TB can vary widely, with sensitivities and specificities ranging from 14% to 85% and from 86% to 100%, respectively. We conclude that the limitations in serodiagnostic studies of childhood TB are manifold, thereby restricting the interpretation of currently available data. Concerns about the methodology used in published studies suggest that conclusions about the eventual value of serodiagnosis cannot be made at this time. However, the available data suggest a potential adjunctive value for serology in the diagnosis of childhood TB. Despite the difficulties noted in this field, there is optimism that the application of novel antigens and the integration of those factors which contribute to the serological responses in childhood TB can lead to useful future diagnostics.
识别易于检测的活动性肺结核(TB)生物标志物是全球卫生工作的重点。此类生物标志物在儿童结核病中具有特殊价值,因为儿童结核病比成人结核病面临更大的诊断挑战。血清抗体可通过能提供极快速结果的简单方法检测。然而,开发准确的结核病血清学诊断检测的尝试均未成功。虽然对成人结核病中针对分枝杆菌抗原的抗体反应已进行了广泛研究和综述,但儿科人群的血清学数据却并非如此。在此,我们评估了关于儿童结核病血清学反应的研究,并在儿童免疫系统发育、年龄范围和结核病表现谱的背景下讨论了研究结果及局限性。我们发现,儿童结核病中针对分枝杆菌抗原的抗体反应差异很大,敏感性和特异性分别在14%至85%以及86%至100%之间。我们得出结论,儿童结核病血清学诊断研究的局限性是多方面的,从而限制了对现有数据的解读。对已发表研究中使用的方法的担忧表明,目前尚无法就血清学诊断的最终价值得出结论。然而,现有数据表明血清学在儿童结核病诊断中具有潜在的辅助价值。尽管该领域存在诸多困难,但人们乐观地认为,新型抗原的应用以及对那些促成儿童结核病血清学反应的因素的整合,可能会带来未来有用的诊断方法。